EDEN — Eden Research Income Statement
0.000.00%
- £13.87m
- £9.11m
- £3.19m
- 20
- 23
- 24
- 10
Annual income statement for Eden Research, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.83 | 1.37 | 1.23 | 1.83 | 3.19 |
Cost of Revenue | |||||
Gross Profit | 0.884 | 0.632 | 0.561 | 0.83 | 1.77 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.18 | 3.9 | 4.44 | 4.39 | 10 |
Operating Profit | -1.36 | -2.54 | -3.21 | -2.57 | -6.84 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.48 | -2.55 | -3.4 | -2.57 | -6.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.13 | -2.26 | -2.78 | -2.24 | -6.49 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.14 | -2.27 | -2.79 | -2.24 | -6.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.14 | -2.27 | -2.79 | -2.24 | -6.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.006 | -0.007 | -0.006 | -0.008 |
Dividends per Share |